Cancer is the leading cause of death globally, the World Health Organisation says, killing almost 10 million people each year.
While about one in six deaths are due to cancer, many forms of the disease can be cured if they are detected early and treatment begins promptly.
Cancer Research UK (Cruk) says 92 per cent of people will survive bowel cancer for five years or more if it is diagnosed in the earliest stage, but the five-year survival rate for patients diagnosed in the final stage, stage four, is only 10 per cent.
Nuformix plc (LON:NFX) is a pharmaceutical development company targeting unmet medical needs in fibrosis and oncology using drug repurposing.
